These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 12154101

  • 1. Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
    Mihailidou AS, Mardini M, Funder JW, Raison M.
    Hypertension; 2002 Aug; 40(2):124-9. PubMed ID: 12154101
    [Abstract] [Full Text] [Related]

  • 2. Hyperaldosteronemia in rabbits inhibits the cardiac sarcolemmal Na(+)-K(+) pump.
    Mihailidou AS, Bundgaard H, Mardini M, Hansen PS, Kjeldsen K, Rasmussen HH.
    Circ Res; 2002 Aug; 86(1):37-42. PubMed ID: 10625303
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN, Thorwald MA, Conte D, Vázquez-Medina JP, Nishiyama A, Ortiz RM.
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
    Arai K, Homma T, Morikawa Y, Ubukata N, Tsuruoka H, Aoki K, Ishikawa H, Mizuno M, Sada T.
    Eur J Pharmacol; 2015 Aug 15; 761():226-34. PubMed ID: 26073023
    [Abstract] [Full Text] [Related]

  • 5. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M.
    Hypertension; 2006 Apr 15; 47(4):656-64. PubMed ID: 16505208
    [Abstract] [Full Text] [Related]

  • 6. The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.
    Eudy RJ, Sahasrabudhe V, Sweeney K, Tugnait M, King-Ahmad A, Near K, Loria P, Banker ME, Piotrowski DW, Boustany-Kari CM.
    J Transl Med; 2011 Oct 21; 9():180. PubMed ID: 22017794
    [Abstract] [Full Text] [Related]

  • 7. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Oct 21; 5(5):354-63. PubMed ID: 14503934
    [Abstract] [Full Text] [Related]

  • 8. Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.
    Takeda Y.
    Hypertens Res; 2004 Nov 21; 27(11):781-9. PubMed ID: 15824460
    [Abstract] [Full Text] [Related]

  • 9. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
    Hermidorff MM, Faria Gde O, Amâncio Gde C, de Assis LV, Isoldi MC.
    Biochem Cell Biol; 2015 Feb 21; 93(1):83-93. PubMed ID: 25488178
    [Abstract] [Full Text] [Related]

  • 10. Alloxan-induced diabetes reduces sarcolemmal Na+-K+ pump function in rabbit ventricular myocytes.
    Hansen PS, Clarke RJ, Buhagiar KA, Hamilton E, Garcia A, White C, Rasmussen HH.
    Am J Physiol Cell Physiol; 2007 Mar 21; 292(3):C1070-7. PubMed ID: 17020934
    [Abstract] [Full Text] [Related]

  • 11. Na+ influx and Na(+)-K+ pump activation during short-term exposure of cardiac myocytes to aldosterone.
    Mihailidou AS, Buhagiar KA, Rasmussen HH.
    Am J Physiol; 1998 Jan 21; 274(1):C175-81. PubMed ID: 9458726
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.
    Hu X, Li S, McMahon EG, Lala DS, Rudolph AE.
    Mini Rev Med Chem; 2005 Aug 21; 5(8):709-18. PubMed ID: 16101407
    [Abstract] [Full Text] [Related]

  • 13. Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C.
    Mihailidou AS, Mardini M, Funder JW.
    Endocrinology; 2004 Feb 21; 145(2):773-80. PubMed ID: 14605011
    [Abstract] [Full Text] [Related]

  • 14. Nongenomic effect of aldosterone on Na+,K+-adenosine triphosphatase in arterial vessels.
    Alzamora R, Marusic ET, Gonzalez M, Michea L.
    Endocrinology; 2003 Apr 21; 144(4):1266-72. PubMed ID: 12639909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Eplerenone: a selective aldosterone receptor antagonist (SARA).
    Delyani JA, Rocha R, Cook CS, Tobert DS, Levin S, Roniker B, Workman DL, Sing YL, Whelihan B.
    Cardiovasc Drug Rev; 2001 Apr 21; 19(3):185-200. PubMed ID: 11607037
    [Abstract] [Full Text] [Related]

  • 19. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
    Wang M, Li Y, Zhou K, Zhang G, Wang Y, Liu T, Zhang Y, Guo A, An Y.
    Cell Physiol Biochem; 2016 Apr 21; 39(3):860-70. PubMed ID: 27497962
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.